Jörn M. Schattenberg

Has grant

University Medical Center of the Johannes Gutenberg University Mainz

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Screening for liver fibrosis - population-based study across European countries

Open Date: 2020-01-01

Close Date: 2025-01-01

Grant: Close

LITMUS - Liver inverstigation: Testing Marker Utility in Steatohepatitis

Open Date: 2017-11-01

Close Date: 2023-10-01

Grant: Close

Bedeutung des Protoonkogens Bcl-3 bei der Initiation und Progression des hepatozellulären Karzinoms (HCC)

Open Date: 2013-10-01

Close Date: 2016-10-01

Grant: Close

The role of apoptosis signaling in the pathophysioogy of non-alcoholic steatohepatitis

Open Date:

Close Date:

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Robim Rodrigues

National Institute on Alcohol Abuse and Alcoholism

UNITED STATES

View details

Joost Boeckmans

Vrije Universiteit Brussel

BELGIUM

View details

Jeffrey V. Lazarus

Associate Professor

University of Barcelona

SPAIN

View details

Alexandra Gatzios

Vrije Universiteit Brussel

BELGIUM

View details

Hannes Hagström

Professor, Senior Consultant Hepatologist

Karolinska Institutet

SWEDEN

View details

Tamara Vanhaecke

Vrije Universiteit Brussel

BELGIUM

View details

Axel Wester

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jörn M. Schattenberg

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis

Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review

Fatty liver disease at the basis of cardiac remodelling and increased heart rate: insights from the UK Biobank

Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease

Identification of fast progressors among patients with nonalcoholic steatohepatitis using machine learning

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients

Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD)

Collaborators (7)

Robim Rodrigues

Joost Boeckmans

Jeffrey V. Lazarus

Alexandra Gatzios

Hannes Hagström

Tamara Vanhaecke

Axel Wester

Make your next move.